Wojciech Tomczak

Wojciech Tomczak

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMartyna Tomczyk-Socha
Martyna Tomczyk-Socha
WTWojciech Tomczak
Wojciech Tomczak
WWWeronika Winkler-Lach
Weronika Winkler-Lach
ATAnna Turno-Kręcicka
Anna Turno-Kręcicka
Pseudoexfoliation syndrome (XFS) is a condition in which excess material builds up not only in the structures of the anterior chamber but also throughout the body. The frequency of the syndrome varies significantly (0.3–18%) depending on the region and the method of examination. Environmental risk factors for XFS include a large number of sunny days, proximity to the equator, dietary factors such as higher consumption of coffee and tea, long-term alcohol consumption, exposure to UV, and outdoor work. The pathognomonic sign of XFS is the presence of white material on the lens capsule and other anterior chamber components. In addition, a characteristic Sampaolesi line can be observed during gonioscopy. Systemic alterations indicative of XFS have been observed in the extracellular matrix of the eyelid skin, the heart, lungs, liver, kidneys, gallbladder, meninges, and endothelium of the blood vessels. XFS is the most common cause of secondary open-angle glaucoma, which is called pseudoexfoliative glaucoma and is more severe than primary open-angle glaucoma. It is plausible that a combination of environmental factors and genetic alterations promotes the onset of pseudoexfoliation syndrome, which requires additional research.

17 March 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ŁNŁukasz Nowak
Łukasz Nowak
DJDawid Janczak
Dawid Janczak
JŁJan Łaszkiewicz
Jan Łaszkiewicz
MGMaciej Guziński
Maciej Guziński
Francesco Del GiudiceFrancesco Del Giudice
Francesco Del Giudice
Wojciech KrajewskiWojciech Krajewski
Wojciech Krajewski
Percutaneous cryoablation (PCA) can be an alternative to partial nephrectomy (PN) in selected patients with stage T1 renal tumours. Existing meta-analyses regarding ablative techniques compared both laparoscopic and PCA with PN. That is why we decided to perform a meta-analysis that focused solely on PCA. The aim of this study was to compare the complications and functional and oncological outcomes between PCA and PN. A systematic literature search was performed in January 2024. Data for dichotomous and continuous variables were expressed as pooled odds ratios (ORs) and mean differences (MDs), both with 95% confidence intervals (CIs). Effect measures for the local recurrence-free survival (LRFS), metastasis-free survival (MFS), cancer-specific survival (CSS) and overall survival (OS) were expressed as pooled hazard ratios with 95% CIs. Among 6487 patients included in the 14 selected papers, 1554 (23.9%) and 4924 (76.1%) underwent PCA and PN, respectively. Compared with the PN group, patients undergoing PCA had significantly lower overall and major postoperative complication rates. There was no difference in renal function between PCA and PN groups. When analysing collective data for cT1 renal carcinoma, PCA was associated with worse LRFS compared with PN. However, subgroup analysis revealed that in the case of PCA, LRFS was not decreased in patients with cT1a tumours. Moreover, patients undergoing robotic-assisted PN had improved LRFS compared with those undergoing PCA. No significant differences were observed between PCA and PN in terms of MFS and CSS. Finally, PCA was associated with worse OS than PN in both collective and subgroup analyses. In conclusion, PCA is associated with favourable postoperative complication rates relative to PN. Regarding LRFS, PCA is not worse than PN in cT1a tumours but has a substantially relevant disadvantage in cT1b tumours. Also, RAPN might be the only surgical modality that provides better LRFS than PCA. In cT1 tumours, PCA shows MFS and CSS comparable to PN. Lastly, PCA is associated with a shorter OS than PN.

19 May 2023 in Biology
Verified
Journal Article
Open access
PDF file
WTWojciech Tomczak
Wojciech Tomczak
WWWeronika Winkler-Lach
Weronika Winkler-Lach
MTMartyna Tomczyk-Socha
Martyna Tomczyk-Socha
MMMarta Misiuk-Hojło
Marta Misiuk-Hojło
The use of stem cells (SCs) has emerged as a promising avenue in ophthalmology, offering potential therapeutic solutions for various vision impairments and degenerative eye diseases. SCs possess the unique ability to self-renew and differentiate into specialised cell types, making them valuable tools for repairing damaged tissues and restoring visual function. Stem cell-based therapies hold significant potential for addressing conditions such as age-related macular degeneration (AMD), retinitis pigmentosa (RP), corneal disorders, and optic nerve damage. Therefore, researchers have explored different sources of stem cells, including embryonic stem cells (ESC), induced pluripotent stem cells (iPSCs), and adult stem cells, for ocular tissue regeneration. Preclinical studies and early-phase clinical trials have demonstrated promising outcomes, with some patients experiencing improved vision following stem cell-based interventions. However, several challenges remain, including optimising the differentiation protocols, ensuring transplanted cells’ safety and long-term viability, and developing effective delivery methods. The field of stem cell research in ophthalmology witnesses a constant influx of new reports and discoveries. To effectively navigate these tons of information, it becomes crucial to summarise and systematise these findings periodically. In light of recent discoveries, this paper demonstrates the potential applications of stem cells in ophthalmology, focusing on their use in various eye tissues, including the cornea, retina, conjunctiva, iris, trabecular meshwork, lens, ciliary body, sclera, and orbital fat.

25 August 2025 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
Wojciech KrajewskiWojciech Krajewski
Wojciech Krajewski
ŁNŁukasz Nowak
Łukasz Nowak
WTWojciech Tomczak
Wojciech Tomczak
KMKlaudia Molik
Klaudia Molik
TOTomasz Ostrowski
Tomasz Ostrowski
TSTomasz Szydełko
Tomasz Szydełko
Introduction Flexible ureterorenoscopy has become one of the cornerstones of minimally invasive treatment for nephrolithiasis. One of the most critical variables in scope design is the outer diameter, improving accessibility. Recently introduced 6.3 Fr ultra-slim digital ureteroscopes may offer clinical advantages over bigger scopes, but there is no data on their performance. Objectives This study aimed to prospectively compare the feasibility, safety, durability, and procedural outcomes of RIRS performed using 6.3 Fr and 7.5 Fr digital disposable ureteroscopes from the same manufacturer, evaluating intraoperative parameters, image quality, access rates, and early postoperative results. Material and methods Thirty adult patients with renal stones < 1.5 cm or cumulative volume < 850 mm³ were enrolled in a single-centre, randomised, prospective trial. All procedures were performed by a single experienced urologist using CE-certified digital disposable ureteroscopes. Lithotripsy was conducted with a high-power holmium laser and a 272-micron fiber. Subjective evaluations of manoeuvrability and image quality were recorded using 5-point Likert scales. Operator workload was assessed with NASA Task Load Index. In-vitro deflection range and image quality were measured before and after clinical use. Postoperative outcomes, complications, and intraoperative stone-free rates were recorded. Results Baseline characteristics were comparable between groups not showing major differences. Ureteral access sheaths were used in 47% of cases. Endoscope insertion into the kidney was successful in all patients. Lithotripsy was complete in 87% of cases using the 6.3 Fr scope and 73% with the 7.5 Fr scope. No statistically significant differences were found in image quality or manoeuvrability scores. Both devices allowed access to the lower pole with and without a working channel instrument. No intraoperative device failures occurred, and postoperative deflection loss was minor and infrequent. One patient required prolonged hospitalisation due to infection while all remaining patients were discharged within 24 h. No ureteral injuries or complications exceeding Clavien-Dindo grade II were observed. Conclusions The results of this study indicate that the 6.3 Fr ultra-slim ureteroscope is a feasible and safe alternative to the bigger 7.5 Fr model, with no compromise in visualisation, manoeuvrability, or device integrity. Given its comparable performance and potential for reduced ureteral trauma, the ultra-slim scope may serve as a valuable tool in modern endourology.

Verified
Journal Article
Open access
PDF file
MTMartyna Tomczyk-Socha
Martyna Tomczyk-Socha
WTWojciech Tomczak
Wojciech Tomczak
ATAnna Turno-Kręcicka
Anna Turno-Kręcicka
Pseudoexfoliation syndrome (PEX) is an important systemic disorder of the extracellular matrix, in which granular amyloid-like protein fibers accumulate in the anterior segment of the eyeball as well as in other organs. PEX is currently considered to be a multifactorial systemic disorder with genetic and environmental risk factors. The aim of this manuscript was to analyze miR expression in PEX. In recent years, an attempt has been made to investigate and describe the level of expression of selected miRs in PEX. Four polymorphisms of genes isolated from the blood that may be related to PEX were identified and miR-122-5p was found to be upregulated in patient blood. Furthermore, 18 miRs were identified with a statistically different expression in the aqueous humor. A significantly elevated expression of miR-125b was found in the anterior lens capsule, and four miRs were described, which may have a significant impact on the development of PEX. Regulatory miR molecules are gaining more and more importance in research aimed at identifying and isolating molecular markers related to the pathogenesis and prognosis of PEX, but further studies are needed.

23 October 2024 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
WTWojciech Tomczak
Wojciech Tomczak
Wojciech KrajewskiWojciech Krajewski
Wojciech Krajewski
JCJoanna Chorbińska
Joanna Chorbińska
ŁNŁukasz Nowak
Łukasz Nowak
KGKatarzyna Grunwald
Katarzyna Grunwald
TSTomasz Szydełko
Tomasz Szydełko
Purpose: Urolithiasis significantly affects patient quality of life, yet the global standard of care predominantly focuses on achieving a stone free status, often ignoring patient reported outcomes. Currently, there are no specific measures available to assess the quality of life in the Polish population suffering from kidney stones. Therefore, this study aimed to develop and validate the Polish version of the Wisconsin Stone Quality of Life Questionnaire. Methods: The translation of WISQOL was carried out in accordance with the best available guidelines. Patients treated for kidney stones at a tertiary centre were recruited and completed both POL-WISQOL and SF36 questionnaires. Comprehensive analyses were conducted to assess internal consistency, inter-item and inter-domain correlations, as well as convergent and construct validity. Additionally, test-retest reliability was evaluated to ensure the accuracy and stability of the findings. Results: A total of 102 participants fully completed both questionnaires and were included in the analysis. The translated survey demonstrated excellent internal consistency (Cronbach’s coefficient 0.967) and significant convergent validity (Spearman’s correlation = 0.847, p < 0.001). Furthermore, an ANOVA with Tukey’s post hoc analysis revealed a significant decline in WISQOL scores between symptomatic and asymptomatic individuals, thereby confirming tool’s construct validity. Conclusion: POL-WISQoL turned out to be a valid disease specific health related quality of life measuring tool. Its widespread utilisation has the potential to shift the standard of care towards patient centered outcomes.